GERMANTOWN, Md. & HILDEN, Germany--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the upcoming launch of the EZ2 Connect product line, a next-level automated ...
Three new innovative instrument launches expand reach into further lab segments and sample preparation customers as QIAGEN strengthens market-leading position QIAsymphony Connect set to start phased ...
Venlo, the Netherlands, Sept. 26, 2024 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its QIAstat-Dx syndromic testing systems and associated assays have ...
Major step towards bringing customer service to critical and syndromic testing QIAsphere mobile App enables real-time and remote test monitoring from anywhere, and will be available for additional ...
VENLO, Netherlands--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it has reached a significant milestone with over 1,000 placements of the EZ2 Connect automated ...
Despite significantly lower sales for HPV testing in the U.S., Qiagen's instrument and consumable sales propped up third quarter results. In the third quarter, Qiagen reported that its sales improved ...
Return of approximately $500 million – maximum approved by shareholders – set to be completed on January 7, 2026Capital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback